[PDF][PDF] A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD
The chromosome 9p21 amyotrophic lateral sclerosis-frontotemporal dementia (ALS-FTD)
locus contains one of the last major unidentified autosomal-dominant genes underlying …
locus contains one of the last major unidentified autosomal-dominant genes underlying …
Blood biomarkers with Parkinson's disease clusters and prognosis: the oxford discovery cohort
M Lawton, F Baig, G Toulson, A Morovat… - Movement …, 2020 - Wiley Online Library
Abstract Background Predicting prognosis in Parkinson's disease (PD) has important
implications for individual prognostication and clinical trials design and targeting novel …
implications for individual prognostication and clinical trials design and targeting novel …
Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease
S Rollinson, N Halliwell, K Young, JB Callister… - Neurobiology of …, 2012 - Elsevier
Frontotemporal lobar degeneration (FTLD) is a highly familial neurodegenerative disease. It
has recently been shown that the most common genetic cause of FTLD and amyotrophic …
has recently been shown that the most common genetic cause of FTLD and amyotrophic …
[HTML][HTML] Plasma oxalate: comparison of methodologies
F Stokes, C Acquaviva-Bourdain, B Hoppe, JC Lieske… - Urolithiasis, 2020 - Springer
Measurement of oxalate in the blood is essential for monitoring primary hyperoxaluria
patients with progressive renal impairment and on dialysis prior to transplantation. As no …
patients with progressive renal impairment and on dialysis prior to transplantation. As no …
Analysis of optineurin in frontotemporal lobar degeneration
S Rollinson, J Bennion, G Toulson, N Halliwell… - Neurobiology of …, 2012 - Elsevier
Frontotemporal lobar degeneration (FTLD) can occur jointly with amyotrophic lateral
sclerosis (ALS), and these 2 conditions share a genetic risk factor on chromosome 9. It has …
sclerosis (ALS), and these 2 conditions share a genetic risk factor on chromosome 9. It has …
SERUM BIOMARKERS FOR PARKINSON'S DISEASE
F Baig, G Toulson, M Lawton, S Evetts, C Ruffmann… - 2016 - jnnp.bmj.com
Objectives There is a critical need to develop robust biomarkers for Parkinson's diasease
(PD) research. We aimed to determine whether a serum biomarker could be used: to predict …
(PD) research. We aimed to determine whether a serum biomarker could be used: to predict …
[CITATION][C] Secretory Leukocyte Protease Inhibitor displays no extracellular protective effect over mature Progranulin under tonic physiological conditions.
G Toulson, S Alan… - DEMENTIA …, 2012 - … ALLSCHWILERSTRASSE 10, CH …